{"id":293,"date":"2008-02-13T18:13:45","date_gmt":"2008-02-13T17:13:45","guid":{"rendered":"http:\/\/www.i-base.info\/qa\/?p=293"},"modified":"2021-11-22T12:18:36","modified_gmt":"2021-11-22T12:18:36","slug":"can-i-take-atripla-as-a-first-line-treatment","status":"publish","type":"post","link":"https:\/\/i-base.info\/qa\/293","title":{"rendered":"Can I take Atripla as a first line treatment?"},"content":{"rendered":"<p>Thank you for your question.<\/p>\n<p>You should be able to take Truvada and Sustiva (two pills once a day) as first line therapy. Once your viral load is undetectable you can then switch to Atripla to take one less pill a day.<\/p>\n<p>This is how Atripla was approved in Europe. This may be due to a number of reasons and one of those reasons might be that there wasn&#8217;t enough data on treatment naive patients.<br \/>\nI hope this is helpful.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>I have got my usual bloods being done in a weeks time (every 3 months etc) and have decided that if my CD4 has declined and my viral load increased I am going to start treatment as I am starting to notice a decline in my overall health. The doctor spoke about Truvada and Sustiva as my 1st line options as they were the best for me, however can I start on the one tablet a day drug instead? I&#8217;ve heard that you need to get your viral load undetectable first, my last count was 77,000. Why is this?<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,39],"tags":[],"class_list":["post-293","post","type-post","status-publish","format-standard","hentry","category-all-topics","category-starting-treatment"],"_links":{"self":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts\/293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/comments?post=293"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts\/293\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/media?parent=293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/categories?post=293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/tags?post=293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}